Loading
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Latest filing published 26 Jun 2025 for Candel Therapeutics, Inc., €21k. Read the official filing
Filing timeline
BuySaleGary J. Nabel
Insider track record
Disclosed buys
4
Disclosed sells
0
T+90 hit rate
67%
T+90 mean return
+10.6%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Gary J. Nabel: trading record in brief
Gary J. Nabel (senior executive) discloses dealings in 3 companies, chiefly Opko Health, Inc., Siga Technologies Inc and Candel Therapeutics, Inc. We count 11 filings; the first trade dates from 9 May 2022 and the latest from 25 June 2025.
No open-market sale appears; the market trades are 4 purchases worth €144k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 share grants and 4 option exercises.
A typical purchase (the median) is worth €24k. Of 4 purchases, 3 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
Most recently, on 26 June 2025, the filings show a share grant worth €21k in Candel Therapeutics, Inc. The most recent open-market purchase was published on 10 January 2024, 1,012 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Gary J. Nabel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
5,353 shares@ US$4.67100.0% of flowCommon StockSEC:0000950170-25-090192:0
19,084 sharesCommon Stock, par value $.0001 per shareSEC:0000950170-25-084856:0
437,500 shares0Common StockSEC:0000950170-24-087030:0
24,712 sharesCommon Stock, par value $.0001 per shareSEC:0000950170-24-073033:0
108,695 shares@ US$0.92563.6% of flowCommon StockSEC:0000950170-24-003699:0
Canonical exit: 7 Apr 2024 (T+90)
14,620 sharesCommon Stock, par value $.0001 per shareSEC:0001209191-23-037429:0
19,285 shares@ US$1.7821.6% of flowCommon StockSEC:0001209191-23-027852:0
Canonical exit: 3 Aug 2023 (T+90)
1,491 shares@ US$2.4950.0004% mcap16.5% of flowCommon StockSEC:0001209191-22-039341:0
Canonical exit: 20 Sept 2022 (T+90)
19,777,514 sharesCommon StockSEC:0001209191-22-038694:0
22,831 sharesCommon Stock, par value $.0001 per shareSEC:0001209191-22-037562:0
6,979 shares@ US$2.6512.3% of flowCommon StockSEC:0001209191-22-030517:0
Canonical exit: 10 Aug 2022 (T+90)
11 of 11 declarations
